Key clinical point : Cognitive impairment may be one of the neurological manifestations of psoriatic arthritis (PsA).
Major finding : Patients with PsA scored worse on the Montreal Cognitive Assessment (MoCA) vs. controls ( P = .01). Additionally, the proportion of patients with cognitive impairment according to MoCA was significantly higher among cases vs. controls (91.9% vs. 58.3%, P = .002).
Study details : The data come from a cross-sectional case-control study involving 37 patients with PsA and 36 healthy controls.
Disclosures: The study did not receive any funding. The authors declared no conflicts of interest.
Source: Garcia LOKL et al. Acta Neurol Belg. 2021 Mar 13. doi: 10.1007/s13760-021-01644-y .